Search Results | Scholarly Articles, Journals, and E-Books

Select item for more details and to access through your institution.

Effect of 4-Year Antioxidant Treatment with α-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial.
Published in:
Diabetes, 2007, v. 56, p. A2
By:
- Ziegler, Dan;
- Low, Phillip A.;
- Boulton, Andrew J.;
- Vinik, Aaron I.;
- Freeman, Roy;
- Samigullin, Rustem;
- Tritschler, Hans;
- Munzel, Ullrich;
- Maus, Joachim;
- Schuette, Klemens;
- Dyck, Peter J.
Publication type:
Article
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
Published in:
2011
By:
- Ziegler D;
- Low PA;
- Litchy WJ;
- Boulton AJ;
- Vinik AI;
- Freeman R;
- Samigullin R;
- Tritschler H;
- Munzel U;
- Maus J;
- Schütte K;
- Dyck PJ;
- Ziegler, Dan;
- Low, Phillip A;
- Litchy, William J;
- Boulton, Andrew J M;
- Vinik, Aaron I;
- Freeman, Roy;
- Samigullin, Rustem;
- Tritschler, Hans
Publication type:
journal article
Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy.
Published in:
Diabetes Care, 2011, v. 34, n. 9, p. 2054, doi. 10.2337/dc11-0503
By:
- ZIEGLER, DAN;
- LOW, PHILLIP A.;
- LITCHY, WILLIAM J.;
- BOULTON, ANDREW J. M.;
- VINIK, AARON I.;
- FREEMAN, ROY;
- SAMIGULLIN, RUSTEM;
- TRITSCHLER, HANS;
- MUNZEL, ULLRICH;
- MAUS, JOACHIM;
- SCHÜTTE, KLEMENS;
- DYCK, PETER J.
Publication type:
Article
Challenges in Design of Multicenter Trials.
Published in:
Diabetes Care, 2007, v. 30, n. 10, p. 2619, doi. 10.2337/dc06-2479
By:
- Dyck, Peter J.;
- Norell, Jane E.;
- Tritschler, Hans;
- Schuette, Klemens;
- Samigullin, Rustem;
- Ziegler, Dan;
- Bastyr III, Edward J.;
- Litchy, William J.;
- O'Brien, Peter C.;
- Skljarevski, Vladimir;
- Low, Phillip A.;
- Dyck, James B.;
- Klein, Christopher J.;
- Melton III, L. Joseph
Publication type:
Article
Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy.
Published in:
Diabetes Care, 2006, v. 29, n. 11, p. 2365, doi. 10.2337/dc06-1216
By:
- Ziegler, Dan;
- Ametov, Alexander;
- Barinov, Alexey;
- Dyck, Peter J.;
- Gurieva, Irina;
- Low, Phillip A.;
- Munzel, Ullrich;
- Yakhno, Nikolai;
- Raz, Itamar;
- Novosadova, Maria;
- Maus, Joachim;
- Samigullin, Rustem
Publication type:
Article
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Published in:
2003
By:
- Ametov, Alexander S.;
- Barinov, Alexei;
- Dyck, Peter J.;
- Hermann, Robert;
- Kozlova, Natalia;
- Litchy, William J.;
- Low, Phillip A.;
- Nehrdich, Detlef;
- Novosadova, Maria;
- O'Brien, Peter C.;
- Reljanovic, Miroslav;
- Samigullin, Rustem;
- Schuette, Klemens;
- Strokov, Igor;
- Tritschler, Hans J.;
- Wessel, Klaus;
- Yakhno, Nikolai;
- Ziegler, Dan;
- SYDNEY Trial Study Group
Publication type:
journal article

Found: 6

Effect of 4-Year Antioxidant Treatment with α-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial.

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.

Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy.

Challenges in Design of Multicenter Trials.

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy.

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.